Continuous Neural Accountability.
1. Introduction
Continuous Neural Accountability is an emerging legal and regulatory concept concerned with the ongoing responsibility of individuals, institutions, corporations, developers, employers, healthcare providers and public authorities for the design, deployment, monitoring and consequences of technologies that interact with, collect information from, or influence the human nervous system.
The concept becomes particularly important with the development of:
Brain–Computer Interfaces (BCIs).
Neural implants and neuroprosthetics.
Neurotechnology and neural stimulation devices.
Artificial intelligence systems analysing brain signals.
Neuroimaging and cognitive monitoring.
Neurological and psychiatric diagnostic technologies.
Workplace and educational neuro-monitoring.
Technologies capable of influencing attention, memory, emotions and cognitive processes.
The central proposition is that accountability for neural technologies must continue throughout their entire operational lifecycle rather than ending when a device is approved, purchased or installed.
For example, a company developing a brain–computer interface should not be responsible only for its initial safety certification. It may also have continuing obligations concerning data security, informed consent, algorithmic accuracy, device updates, adverse neurological effects, discrimination and remedies for affected individuals.
Important legal qualification: Continuous Neural Accountability is not yet a universally recognised, independent legal doctrine. It is a proposed analytical framework derived from established principles of constitutional law, privacy, medical ethics, product liability, data protection, human rights and AI governance.
2. Meaning and Scope
Continuous Neural Accountability has five interconnected dimensions:
Neural autonomy: Protection against unauthorised interference with an individual's mental processes and neurological functions.
Neural privacy: Protection of brain data, neural signals and information inferred from neurological activity.
Technological responsibility: Accountability of developers, manufacturers and operators for the functioning of neural technologies.
Continuous supervision: Ongoing monitoring of risks, safety, accuracy and unintended consequences.
Legal remedies: Access to compensation, correction, investigation and judicial protection when neural technologies cause harm.
The framework recognises that neural technologies create distinctive legal concerns because they may expose information about a person's cognitive processes and potentially influence neurological functioning.
3. Constitutional Foundations of Continuous Neural Accountability
A. Right to privacy and mental autonomy
Neural information may reveal deeply personal information, including neurological conditions, emotional responses, cognitive patterns and behavioural tendencies.
In India, Article 21 of the Constitution provides an important constitutional foundation for protecting such information.
The relevant constitutional interests include:
Privacy and informational self-determination.
Human dignity.
Bodily integrity.
Freedom of thought and conscience.
Personal autonomy.
Protection against arbitrary surveillance.
Freedom from coercive neurological interference.
The constitutional question is not simply whether a person has consented to using a neural device. It is also whether consent is genuinely informed, whether the subsequent processing remains within the agreed purpose and whether the person can withdraw consent where legally applicable.
B. Protection against involuntary neural examination
Article 20(3) protects an accused person against compelled self-incrimination.
This protection becomes especially important when authorities attempt to obtain information through neurological examination, brain-wave measurement or other techniques that may reveal personal knowledge.
The constitutional framework must distinguish between legitimate medical diagnosis and coercive extraction of information for investigative purposes.
C. State responsibility
The State has both negative and positive obligations.
Negative obligations:
Avoid arbitrary neural surveillance.
Prevent involuntary neurological testing.
Avoid unlawful interference with mental privacy.
Refrain from discriminatory use of neural information.
Positive obligations:
Establish appropriate regulatory safeguards.
Protect individuals against misuse by private companies.
Provide effective complaint mechanisms.
Ensure independent oversight of high-risk neurotechnology.
Develop appropriate compensation and enforcement mechanisms.
These principles provide a foundation for applying constitutional accountability to emerging neural technologies.
4. Essential Principles of Continuous Neural Accountability
4.1 Principle of continuous informed consent
Consent must not be treated as a one-time administrative formality.
A neural technology provider should explain:
What neural information is being collected.
Whether the information is being analysed by AI.
Whether the information is transferred to third parties.
Whether the information can be used for commercial purposes.
How long the information will be retained.
Whether the device can influence neurological activity.
What happens when the individual withdraws consent.
For invasive neurotechnology, additional clinical consent, safety and professional obligations may apply.
4.2 Principle of neural data confidentiality
Neural information should receive strong privacy protection because it may reveal information beyond ordinary identifying data.
For example, an EEG-based device might be used to estimate attention or emotional responses. Even when such estimates are imperfect, their misuse can affect employment, insurance, education and personal reputation.
Continuous accountability therefore requires:
Data minimisation.
Encryption.
Restricted access.
Secure storage.
Purpose limitation.
Retention controls.
Appropriate deletion procedures.
Breach reporting and remedial measures.
4.3 Principle of algorithmic accountability
AI-powered neural systems may classify brain signals and generate predictions concerning neurological or cognitive conditions.
A developer or operator should be able to explain:
The purpose of the algorithm.
The nature and quality of training data.
Known limitations.
Error rates and uncertainty.
Potential discriminatory outcomes.
Whether the system has been modified.
Whether a human professional reviews consequential decisions.
A company should not escape responsibility merely by arguing that an algorithm independently generated the result.
4.4 Principle of continuous safety monitoring
Neural devices may produce risks that become apparent only after prolonged use.
Examples include:
Unexpected neurological effects.
Device malfunction.
Infection or complications associated with implants.
Unintended stimulation.
Software vulnerabilities.
Incorrect neural signal interpretation.
Psychological or behavioural consequences.
Continuous accountability requires post-market surveillance, adverse-event reporting, periodic safety evaluation and corrective action.
4.5 Principle of non-discrimination
Neural data should not become an instrument for unfairly categorising individuals.
For instance, an employer should not automatically reject an applicant because a neurotechnology system estimates lower attention, unusual emotional responses or a particular cognitive profile.
Such decisions may be inaccurate, discriminatory and unrelated to the actual requirements of the job.
4.6 Principle of human oversight
High-impact decisions involving neural information should not be left entirely to automated systems.
Human oversight should include:
Qualified professional review.
Explanation of significant decisions.
Opportunities to challenge inaccurate results.
Independent evaluation.
Corrective action where errors are established.
5. Important Case Laws and Judicial Principles
The following cases provide the principal legal foundations. Some directly concern brain-based testing or neurotechnology, while others establish analogous constitutional and privacy principles.
Case 1. Selvi v. State of Karnataka (2010) 7 SCC 263
Directly relevant to neural testing
Court: Supreme Court of India.
Facts: The case concerned the involuntary administration of scientific investigative techniques, including narcoanalysis, polygraph examinations and Brain Electrical Activation Profile (BEAP) testing.
BEAP involves measuring electrical activity in the brain and drawing inferences from neurological responses.
Legal issues:
Whether involuntary neurological testing violates Article 20(3).
Whether the tests interfere with personal liberty.
Whether the results constitute personal testimony.
Whether scientific investigation can override constitutional protections.
Judgment: The Supreme Court held that the involuntary administration of narcoanalysis, polygraph examination and BEAP testing violates Article 20(3) and the protection of personal liberty under Article 21.
The Court also recognised the importance of mental privacy and the individual's freedom against involuntary extraction of personal knowledge.
Relevance to Continuous Neural Accountability:
This judgment is particularly significant because it establishes constitutional limitations on the use of brain-based investigative techniques.
It supports three propositions:
Neurological information cannot be extracted through coercive methods that violate constitutional protections.
Scientific sophistication does not automatically make an investigative technique constitutionally permissible.
The collection and use of brain-related information must respect individual autonomy and dignity.
The judgment is a foundational authority for neural accountability in Indian criminal law.
Case 2. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1
Constitutional foundation
Court: Supreme Court of India, nine-judge Constitution Bench.
Facts: The Court examined whether privacy constitutes a fundamental right under the Indian Constitution.
Judgment: The Court unanimously recognised privacy as a fundamental right protected under Article 21 and the freedoms guaranteed by Part III.
The judgment recognised:
Bodily privacy.
Informational privacy.
Individual autonomy.
Dignity.
Personal decision-making.
Protection against unjustified interference.
It also established the constitutional requirements of legality, legitimate State purpose and proportionality for restrictions on fundamental rights.
Relevance to Continuous Neural Accountability:
Neural information can reveal aspects of an individual's mental and physical condition.
Consequently, unauthorised collection, disclosure or commercial exploitation of identifiable neural information may raise serious constitutional privacy concerns.
The judgment provides a basis for evaluating whether neural surveillance is lawful, necessary and proportionate.
Case 3. Girardi v. Emotiv Inc. (2023), Rol No. 105065-2023
Direct neurotechnology precedent
Court: Supreme Court of Chile.
Decision: 9 August 2023.
Facts: The dispute concerned the Emotiv Insight neurotechnology device, which records electrical brain activity through EEG sensors.
The petitioner raised concerns about the collection, storage and protection of his brain information.
Legal issues:
Protection of personal brain data.
Mental and physical integrity.
Privacy and informational autonomy.
Regulatory oversight of commercial neurotechnology.
Judgment: The Supreme Court of Chile accepted the constitutional protection action and reversed the lower court's decision.
The case required attention to the legal safeguards governing the commercialisation and use of neurotechnology, including appropriate regulatory oversight and protection of brain information.
Relevance to Continuous Neural Accountability:
This is a particularly important international precedent because it directly addresses the legal consequences of commercial neurotechnology.
It illustrates that responsibility extends beyond the initial sale of a device to the subsequent collection, storage and processing of neural information.
It also demonstrates the importance of regulatory scrutiny where a technology can access information associated with human brain activity.
Case 4. Maneka Gandhi v. Union of India (1978) 1 SCC 248
Court: Supreme Court of India.
Legal principle: Procedure affecting personal liberty must be fair, just and reasonable rather than arbitrary, fanciful or oppressive.
Relevance:
A State authority cannot justify intrusive neural monitoring merely by claiming that it serves administrative efficiency or public convenience.
Any restriction involving neural monitoring must satisfy applicable constitutional requirements.
The case provides a procedural fairness foundation for neural accountability.
Case 5. Common Cause v. Union of India (2018) 5 SCC 1
Court: Supreme Court of India, Constitution Bench.
Legal principle: The judgment recognised the constitutional importance of dignity, autonomy and decisional freedom in end-of-life medical decisions.
Relevance:
Neural technologies used in medical treatment must respect the patient's autonomy and dignity.
The decision supports the broader proposition that medical intervention cannot disregard the individual's legally protected choices.
It is an analogous authority rather than a direct ruling on neural technology.
Case 6. Bărbulescu v. Romania (2017) 44 BHRC 1
Court: Grand Chamber, European Court of Human Rights.
Facts: The case concerned workplace monitoring of an employee's electronic communications.
Legal principle: Workplace monitoring must be assessed against privacy rights, including the nature, extent and consequences of surveillance and the availability of safeguards.
Relevance:
The reasoning is relevant by analogy to workplace neuro-monitoring.
If employers use wearable neural devices to monitor attention, fatigue or cognitive performance, similar privacy and proportionality concerns arise.
An employment relationship does not automatically eliminate an individual's privacy rights.
6. Indian Statutory Framework
Although India does not presently have a comprehensive standalone statute devoted exclusively to neural accountability, several existing laws may apply.
| Legislation | Relevance to neural accountability |
|---|---|
| Constitution of India, Articles 14, 19, 20(3) and 21 | Equality, freedom, protection against compelled self-incrimination, privacy and liberty |
| Digital Personal Data Protection Act, 2023 | Processing of identifiable digital personal data, subject to its applicable provisions |
| Information Technology Act, 2000 | Certain forms of unauthorised access, disclosure and cyber-related misconduct |
| Medical Devices Rules, 2017 | Regulation of medical devices, including relevant neurotechnology products |
| New Drugs and Clinical Trials Rules, 2019 | Relevant clinical investigations and trials |
| Consumer Protection Act, 2019 | Defective devices, deficient services and misleading representations |
| Bharatiya Nyaya Sanhita, 2023 | Criminal liability where conduct satisfies applicable offences |
| Mental Healthcare Act, 2017 | Rights, dignity, confidentiality and consent in mental healthcare |
A. Digital Personal Data Protection Act, 2023
Neural data that identifies or relates to an identifiable individual may fall within the Act's definition of digital personal data when processed digitally.
Relevant protections include:
Lawful processing requirements.
Consent and applicable legitimate uses.
Duties of Data Fiduciaries.
Security safeguards.
Individual rights under the Act.
Statutory penalties for specified contraventions.
An important limitation is that the Act does not establish a separate comprehensive category of neural data equivalent to a dedicated neurorights regime. Its application depends on the nature of the information, processing and applicable statutory provisions.
B. Medical Devices Rules, 2017
Neural implants, diagnostic equipment and certain neurological devices may fall within the medical-device regulatory framework.
Relevant regulatory responsibilities include:
Applicable licensing and registration.
Safety and performance requirements.
Quality management.
Clinical evidence where required.
Post-market surveillance.
Reporting and management of adverse events.
A manufacturer cannot treat regulatory approval as permanent immunity from responsibility for subsequent defects or safety failures.
C. Mental Healthcare Act, 2017
The Act is particularly relevant when neural technologies are deployed in psychiatric and mental healthcare.
Its protections concerning dignity, confidentiality, consent and treatment rights are important when technologies interact with an individual's mental health.
Neural monitoring must not be used as a substitute for legally required consent or professional clinical judgment.
7. Continuous Neural Accountability Across the Technology Lifecycle
Continuous accountability should operate at every stage of technological development.
Neural technology accountability lifecycle
Research and development
Ethical review, risk assessment, responsible research and protection of research participants.
Testing and validation
Scientific accuracy, clinical validation, cybersecurity testing and bias evaluation.
Regulatory approval
Applicable licensing, informed consent requirements and safety certification.
Deployment and operation
Secure processing, human oversight, lawful use and transparent monitoring.
Continuous evaluation
Adverse-event monitoring, algorithmic audits, software updates and periodic reassessment.
Incident response
Investigation, notification where required, corrective action and compensation.
Termination and withdrawal
Device deactivation where appropriate, data deletion where legally required and safe removal of implants where clinically indicated.
8. Institutional Accountability: Who Is Legally Responsible?
Continuous Neural Accountability requires a clear allocation of responsibility among the different actors involved.
| Stakeholder | Principal responsibility |
|---|---|
| Neural device manufacturers | Product safety, quality and defect management |
| Software developers | Algorithmic accuracy, testing and security |
| AI companies | Transparency, risk management and appropriate human oversight |
| Hospitals | Patient safety, confidentiality and clinical consent |
| Medical professionals | Professional standards and treatment decisions |
| Employers | Lawful monitoring and protection against discrimination |
| Research institutions | Ethical review and participant protection |
| Data Fiduciaries | Compliance with applicable data protection obligations |
| Government regulators | Licensing, supervision and enforcement |
| Courts | Constitutional protection and effective remedies |
The problem of fragmented liability
Suppose a neural implant malfunctions because of an interaction between defective hardware, an inadequately tested software update and improper clinical supervision.
The manufacturer, software developer and healthcare provider may each have different legal responsibilities.
Continuous Neural Accountability therefore requires investigation of the complete chain of causation rather than automatically assigning responsibility to the last person who operated the device.
However, liability must be determined under the applicable statute, contractual relationship, professional duty and evidence of causation. It does not automatically make every participant jointly liable.
9. Major Legal Challenges
9.1 Neural surveillance
Continuous brain monitoring creates the possibility of monitoring individuals without meaningful awareness or consent.
Potential applications include:
Employee productivity monitoring.
Student attention monitoring.
Behavioural profiling.
Law-enforcement investigations.
Commercial psychological profiling.
The law must distinguish legitimate medical monitoring from unjustified surveillance.
9.2 Neural manipulation
Some technologies can stimulate or influence neural activity.
This creates questions concerning:
Mental autonomy.
Bodily integrity.
Informed consent.
Responsibility for unintended behavioural changes.
Medical negligence.
9.3 Ownership and control of neural information
An important legal question is whether a technology company can claim extensive rights over brain-related information merely because its device collected that information.
The better regulatory approach is to distinguish between intellectual property in the device or software and the individual's rights concerning their personal neural information.
9.4 Algorithmic uncertainty
AI models may interpret neural signals incorrectly.
A prediction concerning attention, memory or emotional state should not automatically be treated as an established medical or psychological fact.
9.5 Cross-border data transfers
Neural information may be collected in one country, processed in another and stored in a third.
This creates questions concerning:
Applicable data protection law.
Jurisdiction.
Regulatory cooperation.
Cross-border disclosure.
Access by foreign authorities.
Responsibility for international data processors.
10. International Regulatory Framework
A. OECD Recommendation on Responsible Innovation in Neurotechnology (2019)
The Organisation for Economic Co-operation and Development adopted its Recommendation on Responsible Innovation in Neurotechnology on 11 December 2019.
It is one of the most important international instruments for developing continuous neural accountability.
Its nine principles address:
Responsible neurotechnology innovation.
Safety assessment.
Inclusivity.
Scientific collaboration.
Societal deliberation.
Institutional oversight.
Protection of personal brain data.
Stewardship and trust.
Anticipation and monitoring of unintended use and misuse.
Particularly important is its requirement for short-term and long-term safety monitoring and mechanisms for identifying harmful unintended consequences.
OECD Legal Instruments+1
B. UNESCO and neurotechnology ethics
UNESCO has highlighted the relationship between neurotechnology, human dignity, personal identity, mental privacy and freedom of thought.
Its work emphasises that neural information must not become an instrument of unauthorised surveillance, manipulation or discrimination.
It also identifies the risks created by combining neurotechnology with artificial intelligence.
UNESCO+1
C. Council of Europe and data protection
The Council of Europe has examined the privacy and data protection implications of neurotechnology and neural data under Convention 108+.
Its expert work considers how existing data protection principles can address the particular risks of neural information processing.
Data Protection
11. Proposed Legal Tests for Continuous Neural Accountability
For academic and regulatory purposes, the following tests can be developed as a proposed framework.
| Legal test | Central question |
|---|---|
| Neural autonomy test | Does the technology interfere with personal mental self-determination? |
| Consent continuity test | Does valid consent cover the current purpose and processing? |
| Neural privacy test | Is the collection and use of brain data legally justified? |
| Safety continuity test | Are neurological risks monitored throughout the device lifecycle? |
| Algorithmic accountability test | Can significant automated conclusions be explained and challenged? |
| Non-discrimination test | Does neural profiling produce unjustified unequal treatment? |
| Human oversight test | Is meaningful professional supervision available? |
| Remedial accountability test | Can affected individuals obtain effective remedies? |
These are proposed analytical tests, not tests already formally adopted by the Supreme Court of India.
12. Proposed Doctrine of Continuous Neural Accountability
A developed doctrine could contain the following legal propositions:
First: No person should be subjected to coercive neural examination contrary to constitutional protections.
Second: Neural information must be protected against unlawful collection, disclosure, manipulation and commercial exploitation.
Third: Consent must remain meaningful throughout the relevant lifecycle of neural data processing.
Fourth: Manufacturers and operators must maintain appropriate safety and security monitoring after deployment.
Fifth: AI-generated neurological assessments must be subject to appropriate validation and human scrutiny.
Sixth: Employers, educational institutions and insurance companies must not use unreliable neural assessments as an automatic basis for consequential decisions.
Seventh: Regulatory authorities must possess adequate powers to investigate neural technology failures and impose applicable corrective measures.
Eighth: Individuals must have access to appropriate legal remedies for violations of their privacy, autonomy, dignity and other protected rights.
13. Critical Academic Analysis
Continuous Neural Accountability represents a significant development in the relationship between constitutional liberty and emerging technological power.
Traditional privacy law primarily addresses the collection, storage and disclosure of personal information. Neural technologies introduce an additional dimension: the possibility of accessing and influencing the neurological processes associated with thought, perception, memory and decision-making.
This creates three fundamental legal problems.
The first is the problem of mental sovereignty.
If neural devices can access or influence cognitive processes, conventional notions of bodily privacy may not adequately address the entire range of risks. Legal protection must also consider the individual's capacity for independent thought and mental self-determination.
The second is the problem of technological responsibility.
Neural technologies increasingly operate through interconnected hardware, software, AI models, cloud platforms and clinical institutions. A malfunction may result from several interacting components.
A suitable accountability framework must therefore identify the responsibilities of every relevant actor without assuming that technological complexity eliminates legal responsibility.
The third is the problem of temporal accountability.
The risks associated with neural technology may change after initial approval. Software modifications, changing algorithms, new commercial applications and emerging scientific evidence may create risks that were not apparent during the original assessment.
Consequently, regulatory responsibility should continue after deployment.
This is where Continuous Neural Accountability becomes particularly significant: it transforms accountability from a one-time compliance obligation into an ongoing legal responsibility.
14. Conclusion
Continuous Neural Accountability can be developed as an emerging principle of constitutional, technological and biomedical governance.
In India, Selvi v. State of Karnataka and K.S. Puttaswamy v. Union of India provide particularly important judicial foundations for protecting individuals against coercive brain-based examination and unjustified interference with privacy and autonomy.
Internationally, Girardi v. Emotiv Inc. demonstrates how courts can address the specific challenges associated with commercial neurotechnology and personal brain data.
The OECD Recommendation of 2019 further provides a foundation for continuous safety monitoring, institutional stewardship and protection against unintended misuse.
Ultimately, the central proposition is:
The more deeply a technology interacts with the human nervous system, the stronger the need for continuous legal accountability, meaningful consent, independent supervision and effective protection of human dignity.
The future development of this doctrine will require coordinated constitutional, medical, technological, data protection and human-rights regulation.
15. Selected Authorities and Further Reading
| Authority | Principal relevance |
|---|---|
| Selvi v. State of Karnataka (2010) 7 SCC 263 | Brain testing and protection against compelled self-incrimination |
| K.S. Puttaswamy v. Union of India (2017) 10 SCC 1 | Privacy, dignity and autonomy |
| Maneka Gandhi v. Union of India (1978) 1 SCC 248 | Fair procedure and personal liberty |
| Common Cause v. Union of India (2018) 5 SCC 1 | Dignity and medical autonomy |
| Bărbulescu v. Romania (2017) | Privacy and workplace surveillance |
| Girardi v. Emotiv Inc. (2023), Rol 105065-2023 | Neural data and commercial neurotechnology |
Important research documents:
OECD Recommendation on Responsible Innovation in Neurotechnology (2019).
Council of Europe Expert Report on Neurotechnology and Neural Data.
UNESCO – Ethics of Neurotechnology.
Supreme Court of India – Selvi judgment.
Supreme Court of India – Puttaswamy judgment.
Chile Supreme Court – Girardi v. Emotiv Inc.
Final academic proposition: Continuous Neural Accountability may be conceptualised as a lifecycle-based legal doctrine requiring every actor involved in the development, deployment and operation of neurotechnology to remain answerable for the protection of neural autonomy, mental privacy, neurological safety and human dignity.

comments